Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.65+0.05 (+1.39%)
Close on Nov 19, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 44M, up 3.3% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44M | +3.3% |
| FY2024 | Dec 31, 2024 | 42M | +97.3% |
| FY2023 | Dec 31, 2023 | 21M | +21435215.0% |
| FY2022 | Dec 31, 2022 | 0M | – |
See a number that looks wrong?